The winners, Nathan Gates, Faith Apostolodes, and Kevin Helm have shared some insights as to what inspired their winning ...

DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...

If you are a Gemini Advanced subscriber, you can access Gemini 2.0 Pro through the model-picker menu on both desktop and ...

Vertex' outgoing R&D chief Peter Mueller - who has just announced his retirement - must feel he is leaving the company in fine shape.

Google’s Najeeb Jarrar says that brands that prioritise mindful marketing and champion data privacy will be the ones that ...

Students learned that many of these careers can be pursued with or without a college degree. Warren County Court Judge and ...

Cupid is the symbol of love: here is how he was represented in the art of Correggio, Caravaggio, Manfredi, and Parmigianino, between light and shadow, passion and fragility.

What does this have to do with the precious metals market? While this is not a direct reason for the precious metals market ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Now, researchers have found the first evidence of changes taking place over the past 20 years in the shape of the inner core. Signs of the core’s deformation appeared in waves from earthquakes ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...